These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 18990940)

  • 1. Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy.
    Peng XH; Qian X; Mao H; Wang AY; Chen ZG; Nie S; Shin DM
    Int J Nanomedicine; 2008; 3(3):311-21. PubMed ID: 18990940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.
    Zhu L; Zhou Z; Mao H; Yang L
    Nanomedicine (Lond); 2017 Jan; 12(1):73-87. PubMed ID: 27876448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Application and advancement of magnetic iron-oxide nanoparticles in tumor-targeted therapy].
    Chen Y; Chen BA
    Chin J Cancer; 2010 Jan; 29(1):125-8. PubMed ID: 20038325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomineralized iron oxide-polydopamine hybrid nanodots for contrast-enhanced
    Wang Z; Wang Y; Wang Y; Wei C; Deng Y; Chen H; Shen J; Ke H
    J Mater Chem B; 2021 Feb; 9(7):1781-1786. PubMed ID: 33594402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of iron oxide nanoparticles with the immune system: challenges and opportunities for their use in nano-oncology.
    Baiu DC; Brazel CS; Bao Y; Otto M
    Curr Pharm Des; 2013; 19(37):6606-21. PubMed ID: 23621531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor-targeted nanoparticles for in vivo imaging of breast cancer.
    Yang L; Peng XH; Wang YA; Wang X; Cao Z; Ni C; Karna P; Zhang X; Wood WC; Gao X; Nie S; Mao H
    Clin Cancer Res; 2009 Jul; 15(14):4722-32. PubMed ID: 19584158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications.
    Gupta AK; Naregalkar RR; Vaidya VD; Gupta M
    Nanomedicine (Lond); 2007 Feb; 2(1):23-39. PubMed ID: 17716188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic iron oxide nanoparticles for tumor-targeted therapy.
    Chen B; Wu W; Wang X
    Curr Cancer Drug Targets; 2011 Feb; 11(2):184-9. PubMed ID: 21158723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-targeted drug delivery and MRI contrast enhancement by chlorotoxin-conjugated iron oxide nanoparticles.
    Sun C; Fang C; Stephen Z; Veiseh O; Hansen S; Lee D; Ellenbogen RG; Olson J; Zhang M
    Nanomedicine (Lond); 2008 Aug; 3(4):495-505. PubMed ID: 18694312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promising approaches in using magnetic nanoparticles in oncology.
    Mikhaylov G; Vasiljeva O
    Biol Chem; 2011 Nov; 392(11):955-60. PubMed ID: 21848508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multimodal magnetic resonance imaging nanoplatform for cancer theranostics.
    Benyettou F; Lalatonne Y; Chebbi I; Di Benedetto M; Serfaty JM; Lecouvey M; Motte L
    Phys Chem Chem Phys; 2011 Jun; 13(21):10020-7. PubMed ID: 21409252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel anti-VEGF targeting and MRI-visible smart drug delivery system for specific diagnosis and therapy of liver cancer.
    Huang H; Li Y; Li C; Wang Y; Sun Y; Wang J
    Macromol Biosci; 2013 Oct; 13(10):1358-68. PubMed ID: 23852809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron oxide nanoparticles as magnetic resonance contrast agent for tumor imaging via folate receptor-targeted delivery.
    Choi H; Choi SR; Zhou R; Kung HF; Chen IW
    Acad Radiol; 2004 Sep; 11(9):996-1004. PubMed ID: 15350580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biofunctionalized, phosphonate-grafted, ultrasmall iron oxide nanoparticles for combined targeted cancer therapy and multimodal imaging.
    Das M; Mishra D; Dhak P; Gupta S; Maiti TK; Basak A; Pramanik P
    Small; 2009 Dec; 5(24):2883-93. PubMed ID: 19856326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron-oxide-based twin nanoplates with strong T
    Wei R; Zhou T; Sun C; Lin H; Yang L; Ren BW; Chen Z; Gao J
    Nanoscale; 2018 Oct; 10(38):18398-18406. PubMed ID: 30256373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facile one-pot fabrication of calcium phosphate-based composite nanoparticles as delivery and MRI contrast agents for macrophages.
    Nakamura M; Oyane A; Kuroiwa K; Shimizu Y; Pyatenko A; Misawa M; Numano T; Kosuge H
    Colloids Surf B Biointerfaces; 2018 Feb; 162():135-145. PubMed ID: 29190464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging the delivery of brain-penetrating PLGA nanoparticles in the brain using magnetic resonance.
    Strohbehn G; Coman D; Han L; Ragheb RR; Fahmy TM; Huttner AJ; Hyder F; Piepmeier JM; Saltzman WM; Zhou J
    J Neurooncol; 2015 Feb; 121(3):441-9. PubMed ID: 25403507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single chain epidermal growth factor receptor antibody conjugated nanoparticles for in vivo tumor targeting and imaging.
    Yang L; Mao H; Wang YA; Cao Z; Peng X; Wang X; Duan H; Ni C; Yuan Q; Adams G; Smith MQ; Wood WC; Gao X; Nie S
    Small; 2009 Feb; 5(2):235-43. PubMed ID: 19089838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic core-shell hybrid nanoparticles for receptor targeted anti-cancer therapy and magnetic resonance imaging.
    Shanavas A; Sasidharan S; Bahadur D; Srivastava R
    J Colloid Interface Sci; 2017 Jan; 486():112-120. PubMed ID: 27697648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Status of Magnetite-Based Core@Shell Structures for Diagnosis and Therapy in Oncology Short running title: Biomedical Applications of Magnetite@Shell Structures.
    Andrade AL; Fabris JD; Domingues RZ; Pereira MC
    Curr Pharm Des; 2015; 21(37):5417-33. PubMed ID: 26377654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.